Annexon, Inc. (ANNX) income statement
ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.10−0.31 (-9.09%)
Close on Nov 20, 2026Market cap $633.78MP/E –Yield 0.00%
Annexon, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $633.78MP/E –Yield 0.00%
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Effective tax rate | – | – | 0.00% | 0.00% | – | – | – | – |
| Returns on capital | ||||||||
| Return on equity | -82.6% | -50.8% | -55.7% | -61.3% | -45.2% | -57.7% | 46.5% | – |
| Return on assets | -65.9% | -42.7% | -46.1% | -49.6% | -40.5% | -31.2% | -74.5% | – |
| Return on tangible assets | -65.9% | -42.7% | -46.1% | -49.6% | -40.5% | -31.2% | -74.5% | – |
| Return on capital employed | -78.1% | -51.4% | -53.0% | -55.1% | -42.8% | -32.5% | -72.3% | – |
| NOPAT | -$170.96M | -$121.72M | -$143.72M | -$145.60M | -$103.26M | -$50.14M | -$25.69M | – |
| Cash flow quality | ||||||||
| OCF / Net income | 0.90 | 0.85 | 0.90 | 0.82 | 0.81 | 0.84 | 0.76 | – |
| FCF / OCF | 100.1% | 100.0% | 100.2% | 105.6% | 101.6% | 100.9% | 100.9% | – |
| FCF / Net income | 0.90 | 0.85 | 0.90 | 0.87 | 0.83 | 0.84 | 0.77 | – |
| FCF / EBITDA | 87.0% | 77.7% | 85.7% | 85.6% | 83.8% | 85.3% | 89.4% | – |
| Unlevered free cash flow | -$186.49M | -$118.02M | -$121.34M | -$122.84M | -$107.76M | -$53.55M | -$28.63M | – |
| Levered free cash flow | -$186.49M | -$118.02M | -$121.34M | -$122.84M | -$107.76M | -$53.55M | -$28.63M | – |
| Efficiency | ||||||||
| CapEx to OCF | -0.07% | -0.01% | -0.16% | -5.6% | -1.6% | -0.87% | -0.94% | – |
| CapEx to depreciation | 0.06 | 0.01 | 0.09 | 3.10 | 0.77 | 0.70 | 0.54 | – |
| Liquidity | ||||||||
| Current ratio | 5.68 | 10.37 | 14.72 | 11.10 | 11.39 | 33.33 | 9.21 | – |
| Quick ratio | 5.68 | 10.37 | 14.72 | 11.10 | 11.39 | 33.33 | 9.21 | – |
| Cash ratio | 5.59 | 10.23 | 14.49 | 10.85 | 11.16 | 33.06 | 8.91 | – |
| Working capital | $199.56M | $285.95M | $245.93M | $225.74M | $225.95M | $343.39M | $40.48M | – |
| Net current asset value | $176.27M | $259.50M | $216.74M | $194.20M | $192.56M | $342.34M | $39.04M | – |
| Leverage | ||||||||
| Assets to equity | 1.31 | 1.19 | 1.19 | 1.23 | 1.24 | 1.03 | -0.50 | – |
| Per share | ||||||||
| EPS (basic) | -1.34 | -1.01 | -1.77 | -2.60 | -3.40 | -4.15 | -88.30 | – |
| EPS (diluted) | -1.34 | -1.01 | -1.77 | -2.60 | -3.40 | -4.15 | -88.30 | – |
| Book value per share | 1.42 | 2.68 | 3.20 | 4.84 | 6.01 | 9.02 | -231.59 | – |
| Tangible book value per share | 1.42 | 2.68 | 3.20 | 4.84 | 6.01 | 9.02 | -231.59 | – |
| Cash per share | 1.60 | 2.85 | 3.31 | 5.09 | 6.29 | 9.20 | 101.28 | – |
| Operating cash flow per share | -1.25 | -1.08 | -1.55 | -2.44 | -2.75 | -1.39 | -65.38 | – |
| Free cash flow per share | -1.25 | -1.08 | -1.55 | -2.57 | -2.79 | -1.40 | -65.99 | – |
| CapEx per share | 0.0009 | 0.0001 | 0.0025 | 0.14 | 0.04 | 0.01 | 0.62 | – |
| Valuation at period end | ||||||||
| Market cap | $755.93M | $604.04M | $337.08M | $238.18M | – | $955.09M | – | – |
| Enterprise value | $567.23M | $263.94M | $171.78M | -$31.32M | – | $584.40M | – | – |
| P/B | 3.6x | 2.1x | 1.3x | 1.0x | – | 2.8x | – | – |
| P/TBV | 3.6x | 2.1x | 1.3x | 1.0x | – | 2.8x | – | – |
| P/OCF | -4.1x | -5.1x | -2.8x | -2.0x | – | -18.0x | – | – |
| EV/EBITDA | – | – | – | 0.2x | – | – | – | – |
| EV/EBIT | – | – | – | 0.2x | – | – | – | – |
| EV/OCF | -3.0x | -2.2x | -1.4x | 0.3x | – | -11.0x | – | – |
| EV/FCF | – | – | – | 0.3x | – | – | – | – |
| Earnings yield | -27.3% | -22.9% | -39.8% | -59.6% | – | -6.6% | – | – |
| FCF yield | -24.7% | -19.5% | -36.0% | -51.6% | – | -5.6% | – | – |
| Shareholder yield | ||||||||
| Dividend per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – |
| Dividend yield | – | – | – | – | – | 0.00% | – | – |
| Per employee | ||||||||
| Total employees | 96 | 100 | 71 | 80 | 61 | 48 | 48 | 48 |
| Operating profit per employee | -$2.25M | -$1.54M | -$2.02M | -$1.82M | -$2.14M | -$1.32M | -$677.46K | – |
| Net income per employee | -$2.15M | -$1.38M | -$1.89M | -$1.77M | -$2.14M | -$1.32M | -$774.65K | – |
| Free cash flow per employee | -$1.94M | -$1.18M | -$1.71M | -$1.54M | -$1.77M | -$1.12M | -$596.35K | – |
| Growth | ||||||||
| EBIT 1Y growth | -40.5% | -7.2% | 1.3% | -11.4% | -105.9% | -95.2% | – | – |
| EBITDA 1Y growth | -41.0% | -7.3% | 1.3% | -11.6% | -104.7% | -96.1% | – | – |
| Net income 1Y growth | -49.6% | -3.0% | 5.4% | -8.9% | -105.5% | -70.5% | – | – |
| Diluted EPS 1Y growth | -32.7% | 42.9% | 31.9% | 23.5% | 18.1% | 95.3% | – | – |
| Operating cash flow 1Y growth | -57.9% | 2.6% | -4.2% | -9.6% | -99.9% | -87.2% | – | – |
| Free cash flow 1Y growth | -58.0% | 2.7% | 1.2% | -14.0% | -101.2% | -87.1% | – | – |
| CapEx 1Y growth | 813.3% | -92.2% | -97.0% | 294.6% | 256.5% | 73.8% | – | – |
| CapEx 3Y CAGR | -72.4% | -79.1% | -25.4% | 190.2% | – | – | – | – |
| CapEx 5Y CAGR | -21.6% | -43.8% | – | – | – | – | – | – |
| Total assets 1Y growth | -20.7% | 17.6% | 4.4% | -0.68% | -19.4% | 613.3% | – | – |
| Total assets 3Y CAGR | -0.89% | 6.8% | -5.8% | 78.8% | – | – | – | – |
| Total assets 5Y CAGR | -4.9% | 47.6% | – | – | – | – | – | – |
| Total equity 1Y growth | -27.8% | 17.0% | 8.4% | -0.31% | -32.6% | 442.7% | -56.5% | – |
| Total equity 3Y CAGR | -2.9% | 8.1% | -10.1% | – | – | – | – | – |
| Total equity 5Y CAGR | -9.3% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.